Top Markets
Coin of the day
InhaleRx Limited InhaleRx Limited

InhaleRx Limited

IRX
Rank in Stocks #35421
Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is... Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is an Australian company primarily engaged in advancing and bringing to market medical drug delivery systems. The firm also dedicates efforts to developing specialized inhaled drug formulations. A notable product within its portfolio is the Medihale inhaler, a distinctive sealed-pod device engineered for compatibility with its inhaled medications. This entity formerly traded as Lifespot Health Ltd, officially adopting the name InhaleRx Limited in October 2021.
Share Price
$0.01657419
Last synced: 2026-03-13
Market Cap
$3.93M
Change (1 day)
0.00%
Change (1 year)
-31.14%
Country
AU
Trade InhaleRx Limited (IRX)

Category

P/S ratio for InhaleRx Limited (IRX)
P/S ratio as of 2026 TTM: 0
According to InhaleRx Limited latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for InhaleRx Limited from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
4.13 -
US
5.03 -
US
2.78 -
IE
3.67 -
US
8.10 -
US